3 recruiting, 1 completed, 1 not yet recruiting, 1 unknown. 2 Phase 1, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 2 | Completed 1, Unknown 1 |
| Phase 3 | 1 | Recruiting 1 |
Follow B-Cell Acute Lymphoblastic Leukaemia: new trials by email Literature Review of B-Cell Acute Lymphoblastic Leukaemia trials Research Report on B-Cell Acute Lymphoblastic Leukaemia
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| CAR-T Treatment in Pediatric and Adult Acute Lymphoblastic Leukemia Acute Lymphoblastic Leukemia, B-Cell Acute Lymphoblastic Leukaemia | Not yet recruiting | Gruppo Italiano Malattie EMatologiche dell'Adulto | 107 | 2026-09-01 | 2026-06-03 | |
| International Study for Treatment of Childhood Relapsed Precursor B-Cell ALL 2020 (IntReALL BCP 2020) Inotuzumab ozogamicin (INO), Blinatumomab - B-Cell Acute Lymphoblastic Leukaemia | Phase 3 | Recruiting | Charite University, Berlin, Germany | 750 | 2026-09-01 | 2026-10-26 |
| A Multi-site Study to Evaluate the Persistence of Protective Immunity to Routine Childhood Vaccinations in Participants With B-ALL/Ly Who Have Received Blinatumomab B-Cell ALL, B-Cell Acute Lymphoblastic Leukaemia | Recruiting | Arkansas Children's Hospital Research Institute | 300 | 2026-01-13 | 2026-10-28 | |
| Blinatumomab Consolidation in Real World B-Cell Acute Lymphoblastic Leukaemia | Recruiting | Medical College of Wisconsin | 200 | 2025-08-28 | 2026-10-01 | |
| Blinatumomab Plus HLA-Mismatched Cellular Therapy for Relapsed/Refractory CD19+ ALL Blinatumomab, Haplo-Mismatched Cell Therapy (HMCT) - B-Cell Acute Lymphoblastic Leukaemia, ALL, Adult | Phase 1 | Completed | Cedars-Sinai Medical Center | 22 | 2020-02-14 | 2025-02-05 |
| CD19-targeting CAR T Cells in Relapsed or Refractory CD19 Positive B-cell Malignancies CD19 CAR T - B-cell Malignancy, B-cell Lymphoma | Phase 1 | Unknown | Shanghai Tong Ren Hospital | 9 | 2018-04-24 | 2020-11-05 |
Burkitt Lymphoma (6) · Precursor Cell Lymphoblastic Leukemia-Lymphoma (2) · Leukemia, B-Cell (1) · Lymphoma (1) · Lymphoma, B-Cell (1) · Neoplasms (1)
DNA Virus Infections (6) · Epstein-Barr Virus Infections (6) · Hemic and Lymphatic Diseases (6) · Herpesviridae Infections (6) · Immune System Diseases (6) · Immunoproliferative Disorders (6) · Infections (6) · Lymphatic Diseases (6) · Lymphoma, Non-Hodgkin (6) · Lymphoproliferative Disorders (6) · Neoplasms by Histologic Type (6) · Tumor Virus Infections (6) · Virus Diseases (6) · Lymphoma (5) · Lymphoma, B-Cell (5)
blinatumomab (2) · Inotuzumab Ozogamicin (1)
Arkansas Children's Hospital Research Institute (1) · Cedars-Sinai Medical Center (1) · Charite University, Berlin, Germany (1) · Gruppo Italiano Malattie EMatologiche dell'Adulto (1) · Medical College of Wisconsin (1) · Shanghai Tong Ren Hospital (1)
United States (3) · Austria (1) · Belgium (1) · China (1) · Czechia (1) · Denmark (1) · Finland (1) · France (1) · Germany (1) · Hungary (1) · Israel (1) · Italy (1) · Netherlands (1) · Norway (1) · Poland (1)
Arend von Stackelberg, Dr. med., MD (1) · Federico Lussana (1) · Lauren Appell, MD (1) · Ligen Liu (1) · Noah Merin, MD PhD (1)
2023 (1)